Detalhe da pesquisa
1.
Perioperative Atezolizumab Plus Fluorouracil, Leucovorin, Oxaliplatin, and Docetaxel for Resectable Esophagogastric Cancer: Interim Results From the Randomized, Multicenter, Phase II/III DANTE/IKF-s633 Trial.
J Clin Oncol
; 42(4): 410-420, 2024 Feb 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37963317